The first half of 2014 has seen less job-cutting by biopharma companies than a year earlier, at least according to one recent report.
The latest monthly job report by Challenger Gray & Christmas, released July 3, showed that biopharmas announced plans to eliminate 4,215 jobs between January and June of this year, down more than one-third (37%) from the 6,709 jobs announced as being jettisoned in the first half of 2013.